Triadin regulates cardiac muscle couplon structure and microdomain Ca 2+ signalling: A path towards ventricular arrhythmias

Cardiovascular Research

Volumn 98, Issue 2, 2013, Pages 187-191

  Chopra, Nagesh ^a   Knollmann, Björn C ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac calcium handling; Cardiac couplon ultrastructure; Triadin; Ventricular arrhythmia

Indexed keywords

CALCIUM BINDING PROTEIN; MESSENGER RNA; MYOSIN HEAVY CHAIN ALPHA; TRIADIN; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ALTERNATIVE RNA SPLICING; BETA ADRENERGIC STIMULATION; CALCIUM SIGNALING; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; DOWN REGULATION; EXCITATION CONTRACTION COUPLING; EXON; GENE OVEREXPRESSION; GENE TARGETING; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; IN VIVO STUDY; LIPID BILAYER; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; NEGATIVE FEEDBACK; NONHUMAN; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SUDDEN DEATH;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CALSEQUESTRIN; CARRIER PROTEINS; EXCITATION CONTRACTION COUPLING; HUMANS; MEMBRANE MICRODOMAINS; MUSCLE PROTEINS; MYOCYTES, CARDIAC; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; TACHYCARDIA, VENTRICULAR;

EID: 84877275652     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt023     Document Type: Review

References (30)

1. GuoW, Jorgensen AO, Jones LR, Campbell KP. Biochemical characterization and molecular cloning of cardiac triadin. J Biol Chem 1996;271:458-465.
2. Caswell AH, Brandt NR, Brunschwig JP, Purkerson S. Localization and partial characterization of the oligomeric disulfide-linked molecular weight 95000 protein (triadin) which binds the ryanodine and dihydropyridine receptors in skeletal muscle triadic vesicles. Biochemistry 1991;30:7507-7513.
3. Peng M, Fan H, Kirley TL, Caswell AH, Schwartz A. Structural diversity of triadin in skeletal muscle and evidence of its existence in heart. FEBS Lett 1994;348:17-20.
4. Kobayashi YM, Jones LR. Identification of triadin 1 as the predominant triadin isoform expressed in mammalian myocardium. J Biol Chem 1999;274:28660-28668.
5. Hong CS, Ji JH, Kim JP, Jung DH, Kim DH. Molecular cloning and characterization of mouse cardiac triadin isoforms. Gene 2001;278:193-199.
6. Chopra N, Yang T, Asghari P, Moore ED, Huke S, Akin B et al. Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation- contraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci USA 2009;106:7636-7641.
7. Thevenon D, Smida-Rezgui S, Chevessier F, Groh S, Henry-Berger J, Beatriz Romero N et al. Human skeletal muscle triadin: gene organization and cloning of the major isoform, Trisk 51. Biochem Biophys Res Commun 2003;303:669-675.
8. Feng Y, Valley MT, Lazar J, Yang AL, Bronson RT, Firestein S et al. SRp38 regulates alternative splicing and is required for Ca(2+) handling in the embryonic heart. Dev Cell 2009;16:528-538.
9. Nader M, Westendorp B, Hawari O, Salih M, Stewart AF, Leenen FH et al. Tail-anchored membrane protein SLMAP is a novel regulator of cardiac function at the sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol 2012;302:H1138-H1145.
10. Kasneci A, Kemeny-Suss NM, Komarova SV, Chalifour LE. Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells. Cardiovasc Res 2009;81:695-702.
11. Knollmann BC, Chopra N, Hlaing T, Akin B, Yang T, Ettensohn K et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2006;116:2510-2520.
12. Knollmann BC. New roles of calsequestrin and triadin in cardiac muscle. J Physiol 2009; 587:3081-3087.
13. Altschafl BA, Arvanitis DA, Fuentes O, Yuan Q, Kranias EG, Valdivia HH. Dual role of junctin in the regulation of ryanodine receptors and calcium release in cardiac ventricular myocytes. J Physiol 2011;589:6063-6080.
14. Terentyev D, Cala SE, Houle TD, Viatchenko-Karpinski S, Gyorke I, Terentyeva R et al. Triadin overexpression stimulates excitation-contraction coupling and increases predisposition to cellular arrhythmia in cardiac myocytes. Circ Res 2005;96:651-658.
15. Knudson CM, Stang KK, Moomaw CR, Slaughter CA, Campbell KP. Primary structure and topological analysis of a skeletal muscle-specific junctional sarcoplasmic reticulum glycoprotein (triadin). J Biol Chem 1993;268:12646-12654.
16. Roux-Buisson N, Cacheux M, Fourest-Lieuvin A, Fauconnier J, Brocard J, Denjoy I et al. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human. Hum Mol Genet 2012;21: 2759-2767.
17. Hong CS, Cho MC, Kwak YG, Song CH, Lee YH, Lim JS et al. Cardiac remodeling and atrial fibrillation in transgenic mice overexpressing junctin. FASEB J 2002;16: 1310-1312.
18. Gergs U, Berndt T, Buskase J, Jones LR, Kirchhefer U, Muller FU et al. On the role of junctin in cardiac Ca2+ handling, contractility, and heart failure. Am J Physiol Heart Circ Physiol 2007;293:H728-H734.
19. Cai WF, Pritchard T, Florea S, Lam CK, Han P, Zhou X et al. Ablation of junctin or triadin is associated with increased cardiac injury following ischaemia/reperfusion. Cardiovasc Res 2012;94:333-341.
20. Gyorke I, Hester N, Jones LR, Gyorke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 2004;86:2121-2128.
21. Priori SG, Chen SR. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ Res 2011;108:871-883.
22. Kirchhefer U, Neumann J, Baba HA, Begrow F, Kobayashi YM, Reinke U et al. Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1. J Biol Chem 2001;276:4142-4149.
23. Kalyanasundaram A, Bal NC, Franzini-Armstrong C, Knollmann BC, Periasamy M. The calsequestrin mutation CASQ2D307H does not affect protein stability and targeting to the junctional sarcoplasmic reticulum but compromises its dynamic regulation of calcium buffering. J Biol Chem 2010;285:3076-3083.
24. Takeshima H, Komazaki S, Nishi M, Iino M, Kangawa K. Junctophilins: a novel family of junctional membrane complex proteins. Mol Cell 2000;6:11-22.
25. Chopra N, Kannankeril PJ, Yang T, Hlaing T, Holinstat I, Ettensohn K et al. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice. Circ Res 2007; 101:617-626.
26. Knollmann BC, Roden DM. A genetic framework for improving arrhythmia therapy. Nature 2008;451:929-936.
27. Rizzi N, Liu N, Napolitano C, Nori A, Turcato F, Colombi B et al. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. Circ Res 2008;103:298-306.
28. Liu N, Ruan Y, Priori SG. Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis 2008;51:23-30.
29. Shen X, Franzini-Armstrong C, Lopez JR, Jones LR, Kobayashi YM, Wang Y et al. Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitationcontraction coupling in skeletal muscle. J Biol Chem 2007;282:37864-37874.
30. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997;276:800-806.